| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vir Biotechnology Inc (NASDAQ: VIR)
VIR Technical Analysis
4
| As on 9th Jun 2023 VIR STOCK Price closed @ 25.43 and we RECOMMEND Sell for LONG-TERM with Stoploss of 26.40 & Strong Sell for SHORT-TERM with Stoploss of 33.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VIRSTOCK Price
| Open | 25.97 | Change | Price | % |
| High | 26.09 | 1 Day | -0.45 | -1.74 |
| Low | 25.34 | 1 Week | -1.24 | -4.65 |
| Close | 25.43 | 1 Month | 0.94 | 3.84 |
| Volume | 817000 | 1 Year | -17.94 | -41.36 |
| 52 Week High 51.16 | 52 Week Low 18.26 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VIR Daily Charts |
VIR Intraday Charts |
Whats New @ Bazaartrend |
VIR Free Analysis |
|
|
VIR Important Levels Intraday
| RESISTANCE | 26.88 |
| RESISTANCE | 26.41 |
| RESISTANCE | 26.13 |
| RESISTANCE | 25.84 |
| SUPPORT | 25.02 |
| SUPPORT | 24.73 |
| SUPPORT | 24.45 |
| SUPPORT | 23.98 |
VIR Forecast April 2024
| 4th UP Forecast | 48.07 |
| 3rd UP Forecast | 40.81 |
| 2nd UP Forecast | 36.32 |
| 1st UP Forecast | 31.83 |
| 1st DOWN Forecast | 19.03 |
| 2nd DOWN Forecast | 14.54 |
| 3rd DOWN Forecast | 10.05 |
| 4th DOWN Forecast | 2.79 |
VIR Weekly Forecast
| 4th UP Forecast | 37.86 |
| 3rd UP Forecast | 33.87 |
| 2nd UP Forecast | 31.41 |
| 1st UP Forecast | 28.95 |
| 1st DOWN Forecast | 21.91 |
| 2nd DOWN Forecast | 19.45 |
| 3rd DOWN Forecast | 16.99 |
| 4th DOWN Forecast | 13.00 |
VIR Forecast2024
| 4th UP Forecast | 81.66 |
| 3rd UP Forecast | 63.63 |
| 2nd UP Forecast | 52.48 |
| 1st UP Forecast | 41.33 |
| 1st DOWN Forecast | 9.53 |
| 2nd DOWN Forecast | -1.62 |
| 3rd DOWN Forecast | -12.77 |
| 4th DOWN Forecast | -30.8 |
Vir Biotechnology Inc ( NASDAQ USA Symbol : VIR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VIR Business Profile
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California. Address: 499 Illinois Street, San Francisco, CA, United States, 94158
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service